Global (AMER, APAC, BRICS and EMEA) Hydroxyprogesterone Caproate Injection Market Research Report 2019-2025 (Includes Business Impact of COVID-19)

  • TBI409382
  • November 06, 2019
  • Global
  • 134 pages
  • TSCIR
                                          

Abstract, Snapshot, Market Analysis & Market Definition: Hydroxyprogesterone Caproate Injection Market

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders. It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No.1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication. AMAG Pharmaceuticals is the leading manufacturer worldwide with the revenue market share of 83%, followed by Mcguff Pharmaceuticals Inc, Aspen Oss B. V, American Regent, Inc. , and Mylan Institutional. North America and Europe are the two biggest selling regions, with the combined sales market share of 72%. In the forecast period, Asia-Pacific is expected to see the rapidest development. In 2019, the market size of Hydroxyprogesterone Caproate Injection is 251.1 million US$ and it will reach 295.5 million US$ in 2025, growing at a CAGR of 1.5% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hydroxyprogesterone Caproate Injection. This report studies the global market size of Hydroxyprogesterone Caproate Injection, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Hydroxyprogesterone Caproate Injection sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

Market Segmentation, Outlook & Regional Insights: Hydroxyprogesterone Caproate Injection Market

Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025: 1 mL Injection 5 mL InjectionThe 5 mL Injection accounted for a larger market share of 52% in 2018, but it was projected to be exceeded by the 1mL one in 2025. Segmentation by Application : Breakdown of data from year 2014 to 2019 and forecast until 2025: Hospitals Injection Clinics InjectionHospital took a larger market share of 51% in 2018, but it was expected to be exceeded by the Clinic in 2025.

Key Players, Recent Developments & Sector Viewpoints: Hydroxyprogesterone Caproate Injection Market

AMAG Pharmaceuticals Mcguff Pharmaceuticals Inc Aspen Oss B.V American Regent, Inc. Mylan Institutional

Key Insights Covered: Exhaustive Hydroxyprogesterone Caproate Injection Market

1. Market size (sales, revenue and growth rate) of Hydroxyprogesterone Caproate Injection industry. 2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Hydroxyprogesterone Caproate Injection industry. 3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Hydroxyprogesterone Caproate Injection industry. 4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Hydroxyprogesterone Caproate Injection industry.

Research Methodology: Hydroxyprogesterone Caproate Injection Market

  • Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  • Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  • Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type

1.3.1 Global Hydroxyprogesterone Caproate Injection Market Size Growth Rate by Type (2019-2025)

1.3.2 1 mL Injection

1.3.3 5 mL Injection
1.4  

1.4.1 Global Hydroxyprogesterone Caproate Injection Market Share by Application (2019-2025)

1.4.2 Hospitals Injection

1.4.2 Clinics Injection
1.5 Study Objectives
1.6 Years Consid
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form